2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
- Home
- Clinical Resources Search
- PQI: Futibatinib (Lytgobi®) Adverse Effects and Supportive Care Management
Futibatinib (Lytgobi®) Adverse Effects and Supportive Care Management
About this PQI
The Fibroblast Growth Factor Receptor (FGFR) pathway plays a key role in multiple fundamental cellular processes. The FGFR inhibitor futibatinib (Lytgobi®) is approved for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements.1 The FGFR inhibitor drug class carries specific adverse effect profiles and monitoring considerations. The purpose of this PQI is to outline adverse effects of futibatinib (Lytgobi®) and provide recommendations to educate, monitor, and support patients appropriately.
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Beizray – An FDA-Approved Albumin Solubilized Formulation of Docetaxel
Last Updated: 11/02/2026
PQI: Retifanlimab-dlwr in Combination with CARBOplatin + PACLItaxel for the First-Line Treatment of Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal
Last Updated: 10/21/2026
PQI: Ruxolitinib Extended Release for the Management of Myelofibrosis, Polycythemia Vera, and Graft-Versus-Host Disease
Last Updated: 10/21/2026
PQI: Gedatolisib Combination Therapy for Locally Advanced or Metastatic Breast Cancer
Last Updated: 10/15/2026
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Inavolisib (Itovebi) Patient Management
Last Updated: 08/01/2026
PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia
Last Updated: 06/30/2026
PQI in Action: Capivasertib (Truqap) Patient Management
Last Updated: 05/06/2026
PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Last Updated: 04/01/2026
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S11 E12: Beyond Service: Supporting Veterans and Their Families Through Cancer Care
Last Updated: 11/21/2026
S11 E13: AI Unfiltered: A Live PQI Podcast on the Future of Oncology
Last Updated: 11/21/2026
S11 E11: The Power of Connection: Building Stronger Teams and Finding Purpose
Last Updated: 11/21/2026
Bispecifics Podcast Mini Series
Last Updated: 11/21/2026
Toolkit
Toolkit
Toolkit
Toolkit
Veteran Community Care Workflow Checklist
Last Updated: 11/05/2026
VA Community Care Referral and Authorization Checklist
Last Updated: 11/05/2026
Toolkit: Simplify CLL Tracking in Oncology Practices
Last Updated: 10/15/2025
Toolkit: Optimize CLL Care in Epic
Last Updated: 10/15/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 01/06/2026
Treatment Support Kit: Bispecific (T-Cell Engager)
Last Updated: 12/12/2025
Treatment Support Kit: Zanidatamab-hrii
Last Updated: 09/28/2025
Treatment Support Kit: Avutometinib and Defactinib
Last Updated: 08/06/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 11/21/2026
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Last Updated: 11/21/2026
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Last Updated: 11/21/2026
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Last Updated: 11/21/2026
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
FOLFIRI
Last Updated: 07/09/2026
Albumin-Bound Paclitaxel
Last Updated: 07/08/2026
Gemcitabine
Last Updated: 07/07/2026
CAR-T
Patient Education Sheet
Patient Education Sheet
Patient Education Sheet
CAR-T Toxicities Can Move Fast. Recognition Must Move Faster
Last Updated: 09/04/2026
Filgrastim
Last Updated: 01/19/2026
Pegfilgrastim
Last Updated: 01/19/2026
Pamidronate
Last Updated: 12/15/2025